Prestige Consumer Healthcare Inc (PBH)
70.09
-0.04
(-0.06%)
USD |
NYSE |
Apr 25, 13:20
Prestige Consumer Healthcare Accounts Receivable (Quarterly): 174.29M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 174.29M |
September 30, 2023 | 158.46M |
June 30, 2023 | 157.95M |
March 31, 2023 | 183.37M |
December 31, 2022 | 157.08M |
September 30, 2022 | 145.99M |
June 30, 2022 | 145.45M |
March 31, 2022 | 159.00M |
December 31, 2021 | 134.26M |
September 30, 2021 | 146.55M |
June 30, 2021 | 130.35M |
March 31, 2021 | 114.67M |
December 31, 2020 | 116.00M |
September 30, 2020 | 122.21M |
June 30, 2020 | 112.32M |
March 31, 2020 | 149.96M |
December 31, 2019 | 144.50M |
September 30, 2019 | 142.60M |
June 30, 2019 | 142.93M |
March 31, 2019 | 148.08M |
December 31, 2018 | 140.58M |
September 30, 2018 | 153.85M |
June 30, 2018 | 150.39M |
March 31, 2018 | 140.10M |
December 31, 2017 | 150.42M |
Date | Value |
---|---|
September 30, 2017 | 145.42M |
June 30, 2017 | 134.72M |
March 31, 2017 | 135.33M |
December 31, 2016 | 104.10M |
September 30, 2016 | 91.86M |
June 30, 2016 | 87.39M |
March 31, 2016 | 93.99M |
December 31, 2015 | 83.65M |
September 30, 2015 | 89.60M |
June 30, 2015 | 83.62M |
March 31, 2015 | 85.50M |
December 31, 2014 | 84.69M |
September 30, 2014 | 96.47M |
June 30, 2014 | 56.77M |
March 31, 2014 | 63.69M |
December 31, 2013 | 64.48M |
September 30, 2013 | 79.80M |
June 30, 2013 | 61.34M |
March 31, 2013 | 72.44M |
December 31, 2012 | 73.75M |
September 30, 2012 | 83.48M |
June 30, 2012 | 45.77M |
March 31, 2012 | 50.86M |
December 31, 2011 | 50.16M |
September 30, 2011 | 49.44M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
112.32M
Minimum
Jun 2020
183.37M
Maximum
Mar 2023
144.10M
Average
145.45M
Median
Jun 2022
Accounts Receivable (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.759M |
Palatin Technologies Inc | 2.346M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |